» Articles » PMID: 20080598

Mammalian Mst1 and Mst2 Kinases Play Essential Roles in Organ Size Control and Tumor Suppression

Overview
Specialty Science
Date 2010 Jan 19
PMID 20080598
Citations 316
Authors
Affiliations
Soon will be listed here.
Abstract

Control of organ size by cell proliferation and survival is a fundamental developmental process, and its deregulation leads to cancer. However, the molecular mechanism underlying organ size control remains elusive in vertebrates. In Drosophila, the Hippo (Hpo) signaling pathway controls organ size by both restricting cell growth and proliferation and promoting cell death. Here we investigated whether mammals also require the Hpo pathway to control organ size and adult tissue homeostasis. We found that Mst1 and Mst2, the two mouse homologs of the Drosophila Hpo, control the sizes of some, but not all organs, in mice, and Mst1 and Mst2 act as tumor suppressors by restricting cell proliferation and survival. We show that Mst1 and Mst2 play redundant roles, and removal of both resulted in early lethality in mouse embryos. Importantly, tumors developed in the liver with a substantial increase of the stem/progenitor cells by 6 months after removing Mst1 and Mst2 postnatally. We show that Mst1 and Mst2 were required in vivo to control Yap phosphorylation and activity. Interestingly, apoptosis induced by TNFalpha was blocked in the Mst1 and Mst2 double-mutant cells both in vivo and in vitro. As TNFalpha is a pleiotropic inflammatory cytokine affecting most organs by regulating cell proliferation and cell death, resistance to TNFalpha-induced cell death may also contribute significantly to tumor formation in the absence of Mst1 and Mst2.

Citing Articles

Decoding gene expression profiles of Hippo signaling pathway components in breast cancer.

Bhavnagari H, Shah F Mol Biol Rep. 2025; 52(1):216.

PMID: 39928181 DOI: 10.1007/s11033-025-10299-4.


Activation of the conserved Hippo kinases by inflammasome-triggered proteolytic cleavage controls programmed cell death in macrophages.

Su Y, Quagliato S, St Louis B, Abdelaziz M, He Y, Bondage D Proc Natl Acad Sci U S A. 2025; 122(5):e2418613122.

PMID: 39883842 PMC: 11804562. DOI: 10.1073/pnas.2418613122.


The Cell Polarity Protein MPP5/PALS1 Controls the Subcellular Localization of the Oncogenes and in Liver Cancer.

Toth M, Wan S, Schmitt J, Birner P, Wei T, von Bubnoff F Int J Mol Sci. 2025; 26(2.

PMID: 39859373 PMC: 11766031. DOI: 10.3390/ijms26020660.


Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.

Jeon S, Jeon Y, Lim J, Kim Y, Cha B, Kim W Signal Transduct Target Ther. 2025; 10(1):4.

PMID: 39757214 PMC: 11701242. DOI: 10.1038/s41392-024-02070-1.


Hitting the target: cell signaling pathways modulation by extracellular vesicles.

Cerrotti G, Buratta S, Latella R, Calzoni E, Cusumano G, Bertoldi A Extracell Vesicles Circ Nucl Acids. 2024; 5(3):527-552.

PMID: 39697631 PMC: 11648414. DOI: 10.20517/evcna.2024.16.


References
1.
Xu T, Wang W, Zhang S, Stewart R, Yu W . Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995; 121(4):1053-63. DOI: 10.1242/dev.121.4.1053. View

2.
Pan D . Hippo signaling in organ size control. Genes Dev. 2007; 21(8):886-97. DOI: 10.1101/gad.1536007. View

3.
Thorgeirsson S . Hepatic stem cells in liver regeneration. FASEB J. 1996; 10(11):1249-56. View

4.
Hao Y, Chun A, Cheung K, Rashidi B, Yang X . Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem. 2007; 283(9):5496-509. DOI: 10.1074/jbc.M709037200. View

5.
Robin C, Ottersbach K, Durand C, Peeters M, Vanes L, Tybulewicz V . An unexpected role for IL-3 in the embryonic development of hematopoietic stem cells. Dev Cell. 2006; 11(2):171-80. DOI: 10.1016/j.devcel.2006.07.002. View